STUDY OBJECTIVE: To evaluate an intervention designed to curtail an outbreak of hepatitis A among gay men, especially the young and sexually active, by promoting their free vaccination. DESIGN: The study analysed routine passive surveillance data, carried out questionnaire and serological surveys of vaccinees, and surveys among the target population in non-clinical venues. SETTING AND INTERVENTION: 15 000 free doses of hepatitis A vaccine were made available through clinics with large gay clienteles, or at gay events, and advertised by various means, in Montréal, Canada, from August 1996 to November 1997. Simultaneous vaccination against hepatitis B (always free for gay men) was also encouraged. PARTICIPANTS: Information was obtained from persons with the disease during the epidemic period, a sample of men requesting vaccination, and five community samples of gay men. MAIN RESULTS: The outbreak involved 376 gay men and the vaccine was distributed to approximately 10 000. Vaccinees were older than cases, but had many sex partners and comprised more food handlers. Special vaccination clinics at gay events were well attended but did not reach more high risk men than regular medical venues. A self reported vaccine coverage of 49% was achieved, but 26% of vaccinees already had anti-HAV antibodies. Disease incidence declined rapidly during the campaign. CONCLUSIONS: The intervention nearly tripled self reported hepatitis A vaccine coverage but its late start precludes proving that it caused the subsequent drop in incidence. However, it also increased hepatitis B vaccination and it is believed it improved links between gay men, public health, clinicians and community groups.
STUDY OBJECTIVE: To evaluate an intervention designed to curtail an outbreak of hepatitis A among gay men, especially the young and sexually active, by promoting their free vaccination. DESIGN: The study analysed routine passive surveillance data, carried out questionnaire and serological surveys of vaccinees, and surveys among the target population in non-clinical venues. SETTING AND INTERVENTION: 15 000 free doses of hepatitis A vaccine were made available through clinics with large gay clienteles, or at gay events, and advertised by various means, in Montréal, Canada, from August 1996 to November 1997. Simultaneous vaccination against hepatitis B (always free for gay men) was also encouraged. PARTICIPANTS: Information was obtained from persons with the disease during the epidemic period, a sample of men requesting vaccination, and five community samples of gay men. MAIN RESULTS: The outbreak involved 376 gay men and the vaccine was distributed to approximately 10 000. Vaccinees were older than cases, but had many sex partners and comprised more food handlers. Special vaccination clinics at gay events were well attended but did not reach more high risk men than regular medical venues. A self reported vaccine coverage of 49% was achieved, but 26% of vaccinees already had anti-HAV antibodies. Disease incidence declined rapidly during the campaign. CONCLUSIONS: The intervention nearly tripled self reported hepatitis A vaccine coverage but its late start precludes proving that it caused the subsequent drop in incidence. However, it also increased hepatitis B vaccination and it is believed it improved links between gay men, public health, clinicians and community groups.
Authors: A Werzberger; B Mensch; B Kuter; L Brown; J Lewis; R Sitrin; W Miller; D Shouval; B Wiens; G Calandra Journal: N Engl J Med Date: 1992-08-13 Impact factor: 91.245
Authors: B Christenson; C Broström; M Böttiger; J Hermanson; O Weiland; G Ryd; J V Berg; R Sjöblom Journal: Am J Epidemiol Date: 1982-10 Impact factor: 4.897
Authors: Andrea C Tricco; Ba' Pham; Bernard Duval; Gaston De Serres; Vladimir Gilca; Linda Vrbova; Andrea Anonychuk; Murray Krahn; David Moher Journal: BMC Health Serv Res Date: 2006-12-08 Impact factor: 2.655
Authors: Ba' Pham; Bernard Duval; Gaston De Serres; Vladimir Gilca; Andrea C Tricco; Jan Ochnio; David W Scheifele Journal: BMC Infect Dis Date: 2005-07-07 Impact factor: 3.090
Authors: Magalie Canuel; Gaston De Serres; Bernard Duval; Rodica Gilca; Philippe De Wals; Vladimir Gilca Journal: BMC Infect Dis Date: 2007-04-18 Impact factor: 3.090